Literature DB >> 28431140

Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.

Linda Kwakkenbos1,2,3, Brett D Thombs1,2,4,5,6,7,8, Dinesh Khanna9, Marie-Eve Carrier1, Murray Baron1,4, Daniel E Furst10, Karen Gottesman11, Frank van den Hoogen12,13, Vanessa L Malcarne14,15, Maureen D Mayes16, Luc Mouthon17,18, Warren R Nielson19,20, Serge Poiraudeau17,21,22, Robert Riggs11, Maureen Sauvé23,24, Fredrick Wigley25, Marie Hudson1,4, Susan J Bartlett4,25,26.   

Abstract

Objective: The Patient-Reported Outcomes Measurement Information System (PROMIS)-29 assesses seven health-related quality of life domains plus pain intensity. The objective was to examine PROMIS-29v2 validity and explore clinical associations in patients with SSc.
Methods: English-speaking SSc patients in the Scleroderma Patient-centered Intervention Network Cohort from 26 sites in Canada, the USA and the UK completed the PROMIS-29v2 between July 2014 and November 2015. Enrolling physicians provided medical data. To examine convergent validity, hypotheses on the direction and magnitude of correlations with legacy measures were tested. For clinical associations, t -tests were conducted for dichotomous variables and PROMIS-29v2 domain scores. Effect sizes (ESs) were labelled as small (<0.25), small to moderate (0.25-0.45), moderate (0.46-0.55), moderate to large (0.56-0.75) and large (>0.75).
Results: There were 696 patients (87% female), mean ( s . d .) disease duration 11.6 (8.7) years, 57% with limited cutaneous subtype. Validity indices were consistent with seven of nine hypotheses (| r | =0.51-0.87, P < 0.001), with minor divergence for two hypotheses. Gastrointestinal involvement was associated with significantly worse outcomes for all eight PROMIS-29v2 domains (moderate or moderate to large ES in six of eight). Presence of joint contractures was associated with significant decrements in seven domains (small or small to moderate ESs). Skin thickening, diffuse cutaneous subtype and presence of overlap syndromes were significantly associated (small or small to moderate ESs) with five or six domains.
Conclusion: This study further establishes the validity of the PROMIS-29v2 in SSc and underlines the importance of gastrointestinal symptoms and joint contractures in reduced health-related quality of life.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  PROMIS; clinical; quality of life; systemic sclerosis; validation

Mesh:

Year:  2017        PMID: 28431140      PMCID: PMC5850469          DOI: 10.1093/rheumatology/kex055

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  30 in total

Review 1.  Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda.

Authors:  Brett D Thombs; Wim van Lankveld; Marielle Bassel; Murray Baron; Robert Buzza; Shirley Haslam; Jennifer A Haythornthwaite; Marie Hudson; Lisa R Jewett; Ruby Knafo; Linda Kwakkenbos; Vanessa L Malcarne; Katherine Milette; Sarosh J Motivala; Evan G Newton; Warren R Nielson; Marion Pacy; Ilya Razykov; Orit Schieir; Suzanne Taillefer; Maureen Worron-Sauve
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-08       Impact factor: 4.794

2.  Quality criteria were proposed for measurement properties of health status questionnaires.

Authors:  Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

3.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

4.  Brief fear of negative evaluation scale-revised.

Authors:  R Nicholas Carleton; Donald R McCreary; Peter J Norton; Gordon J G Asmundson
Journal:  Depress Anxiety       Date:  2006       Impact factor: 6.505

Review 5.  Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.

Authors:  Stavros K Ntoumazios; Paraskevi V Voulgari; Konstantinos Potsis; Evagelos Koutis; Niki Tsifetaki; Dimitrios A Assimakopoulos
Journal:  Semin Arthritis Rheum       Date:  2006-10-11       Impact factor: 5.532

6.  Social anxiety and fear of negative evaluation: construct validity of the BFNE-II.

Authors:  R Nicholas Carleton; Kelsey C Collimore; Gordon J G Asmundson
Journal:  J Anxiety Disord       Date:  2006-05-03

7.  The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2010-02-19       Impact factor: 4.147

8.  Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap.

Authors:  M T Duruöz; S Poiraudeau; J Fermanian; C J Menkes; B Amor; M Dougados; M Revel
Journal:  J Rheumatol       Date:  1996-07       Impact factor: 4.666

9.  The PHQ-8 as a measure of current depression in the general population.

Authors:  Kurt Kroenke; Tara W Strine; Robert L Spitzer; Janet B W Williams; Joyce T Berry; Ali H Mokdad
Journal:  J Affect Disord       Date:  2008-08-27       Impact factor: 4.839

10.  The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context.

Authors:  Linda Kwakkenbos; Lisa R Jewett; Murray Baron; Susan J Bartlett; Dan Furst; Karen Gottesman; Dinesh Khanna; Vanessa L Malcarne; Maureen D Mayes; Luc Mouthon; Serge Poiraudeau; Maureen Sauve; Warren R Nielson; Janet L Poole; Shervin Assassi; Isabelle Boutron; Carolyn Ells; Cornelia Hm van den Ende; Marie Hudson; Ann Impens; Annett Körner; Catarina Leite; Angela Costa Maia; Cindy Mendelson; Janet Pope; Russell J Steele; Maria E Suarez-Almazor; Sara Ahmed; Stephanie Coronado-Montoya; Vanessa C Delisle; Shadi Gholizadeh; Yeona Jang; Brooke Levis; Katherine Milette; Sarah D Mills; Ilya Razykov; Rina S Fox; Brett D Thombs
Journal:  BMJ Open       Date:  2013-08-07       Impact factor: 2.692

View more
  22 in total

1.  Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial.

Authors:  Lorinda Chung; Cathie Spino; Richard McLain; Sindhu R Johnson; Christopher P Denton; Jerry A Molitor; Virginia D Steen; Robert Lafyatis; Robert W Simms; Suzanne Kafaja; Tracy M Frech; Vivien Hsu; Robyn T Domsic; Janet E Pope; Jessica K Gordon; Maureen D Mayes; Nora Sandorfi; Faye N Hant; Elana J Bernstein; Soumya Chatterjee; Flavia V Castelino; Ali Ajam; Yannick Allanore; Marco Matucci-Cerinic; Michael L Whitfield; Oliver Distler; Ora Singer; Amber Young; Vivek Nagaraja; David A Fox; Daniel E Furst; Dinesh Khanna
Journal:  Lancet Rheumatol       Date:  2020-10-19

Review 2.  Patient-reported outcome instruments in clinical trials of systemic sclerosis.

Authors:  John D Pauling; Joana Caetano; Corrado Campochiaro; Giacomo De Luca; Ana Maria Gheorghiu; Maria Grazia Lazzaroni; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2019-11-25

3.  Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND): Study protocol.

Authors:  Marie-Eve Carrier; Linda Kwakkenbos; Isabelle Boutron; Joep Welling; Maureen Sauve; Cornelia van den Ende; Anne A Schouffoer; Marie Hudson; Brett D Thombs; Luc Mouthon
Journal:  J Scleroderma Relat Disord       Date:  2017-10-16

4.  Reliability, validity, and responsiveness to change of the Patient-Reported Outcomes Measurement Information System self-efficacy for managing chronic conditions measure in systemic sclerosis.

Authors:  Susan L Murphy; Veronica J Berrocal; Janet L Poole; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2021-10-20

5.  Randomized Controlled Trial to Evaluate an Internet-Based Self-Management Program in Systemic Sclerosis.

Authors:  Dinesh Khanna; Jennifer Serrano; Veronica J Berrocal; Richard M Silver; Pedro Cuencas; Sharon L Newbill; Josephine Battyany; Cynthia Maxwell; Mary Alore; Laura Dyas; Robert Riggs; Kerri Connolly; Saville Kellner; Jody J Fisher; Erica Bush; Anjali Sachdeva; Luke Evnin; Dennis W Raisch; Janet L Poole
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-02-05       Impact factor: 4.794

6.  Fatigue and Its Association With Social Participation, Functioning, and Quality of Life in Systemic Sclerosis.

Authors:  Susan L Murphy; Anna L Kratz; Daniel Whibley; Janet L Poole; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-02-05       Impact factor: 4.794

7.  Self-management interventions in systemic sclerosis: A systematic review.

Authors:  Robyn K Wojeck; Donald E Bailey; Tamara J Somers; Mitchell R Knisely
Journal:  Res Nurs Health       Date:  2021-03-02       Impact factor: 2.228

8.  Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes.

Authors:  Alain Lescoat; Susan L Murphy; David Roofeh; John D Pauling; Michael Hughes; Robert Sandler; François Zimmermann; Rachel Wessel; Whitney Townsend; Lorinda Chung; Christopher P Denton; Peter A Merkel; Virginia Steen; Yannick Allanore; Francesco Del Galdo; Dominique Godard; David Cella; Sue Farrington; Maya H Buch; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2020-10-05

9.  The Relationship Between Autonomic Dysfunction of the Gastrointestinal Tract and Emotional Distress in Patients With Systemic Sclerosis.

Authors:  Dana DiRenzo; James Russell; Clifton O Bingham; Zsuzsanna McMahan
Journal:  J Clin Rheumatol       Date:  2021-01-01       Impact factor: 3.902

10.  Pain and Self-Efficacy Among Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.

Authors:  Robyn K Wojeck; Susan G Silva; Donald E Bailey; Mitchell R Knisely; Linda Kwakkenbos; Marie-Eve Carrier; Warren R Nielson; Susan J Bartlett; Janet Pope; Brett D Thombs
Journal:  Nurs Res       Date:  2021 Set/Oct 01       Impact factor: 2.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.